¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ 44th Korean College of Rheumatolgy Annual Scientific Meeting and the 18th International Symposium (KCR2024)-¼Â°³¯ : 2024-05-18

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ 44th Korean College of Rheumatolgy Annual Scientific Meeting and the 18th International Symposium (KCR2024)-¼Â°³¯ : 2024-05-18
±³À°ÀÏÀÚ : 2024-05-18
±³À°Àå¼Ò : ÄÜ·¡µå ¼­¿ï

±³À°ÁÖÁ¦ : (¿Â.¿ÀÇÁ º´Çà) 44th Korean College of Rheumatolgy Annual Scientific Meeting and the 18th International Symposium (KCR2024)-¼Â°³¯

ÁÖÃÖ±â°ü : ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ
´ã´çÀÚ : ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ
¿¬¶ôó : 02-794-2630  

À̸ÞÀÏ : webmaster@rheum.or.kr

±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Á¤Çü¿Ü°ú, ¿µ»óÀÇÇаú, ÀçÈ°ÀÇÇаú, °¡Á¤ÀÇÇаú

Âü¼®¿¹»óÀÎ : 1000¸í
Èñ¸ÁÆòÁ¡ : 5Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 13 ½Ã°£ 50ºÐ

¼¼ºÎ¼ö°­·á : 250,000¿ø  

ºñ°í "»çÀüµî·Ï ȸ¿ø Àü¹®ÀÇ ÀüÀÓÀÇ 180,000¿ø, ºñȸ¿ø Àü¹®ÀÇ ÀüÀÓÀÇ 230,000¿ø 

ÇöÀåµî·Ï ȸ¿ø Àü¹®ÀÇ ÀüÀÓÀÇ 200,000¿ø, ºñȸ¿ø Àü¹®ÀÇ ÀüÀÓÀÇ 250,000¿ø" 


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 05¿ù 18ÀÏ Room 1 08:00~08:40 Role of SIMPONI in Treatment Sequencing for Patients with axSpA ÀÌ°æ¾ð(¼øõÇâ´ëÇб³)

±³À°½Ã°£ 05¿ù 18ÀÏ Room 1 09:00~10:00 ESG in Healthcare: Role of Academic Society ±è±¤Á¡(°¡Å縯´ëÇб³)

±³À°½Ã°£ 05¿ù 18ÀÏ Room 1 10:30~11:00 ASAS Consensus Definition of Early Axial Spondyloarthritis Sofia Ramiro(Leiden Univ. Medical Center, Netherlands)

±³À°½Ã°£ 05¿ù 18ÀÏ Room 1 11:00~11:30 Radiologic Findings of Early Axial Spondyloarthirits À̽ÂÈÆ(ÇѾç´ëÇб³)

Åä·Ð 05¿ù 18ÀÏ Room 1 11:30~12:00 Discussion ()

±³À°½Ã°£ 05¿ù 18ÀÏ Room 1 12:00~12:40 What Impact May Arise from the Early-stage Inhibition of IL-17A in AS? ±èÅÂÁ¾(Àü³²´ëÇб³)

±³À°½Ã°£ 05¿ù 18ÀÏ Room 1 13:00~13:30 Novel Mechanisms and Emerging Therapeutic Targets for OA Frank Beier(Western Univ., Canada)

±³À°½Ã°£ 05¿ù 18ÀÏ Room 1 13:30~14:00 CAR-T Cell Therapy in Systemic Lupus Erythematosus Georg Schett(Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany)

Åä·Ð 05¿ù 18ÀÏ Room 1 14:00~14:30 Discussion ()

±³À°½Ã°£ 05¿ù 18ÀÏ Room 2 08:00~08:40 Advanced Treatment Options for AS: How to Choose? ¹®¼öÁø(°¡Å縯´ëÇб³)

±³À°½Ã°£ 05¿ù 18ÀÏ Room 2 10:30~10:40 (±¸¿¬ ¹ßÇ¥) Comparative effectiveness of subcutaneous sarilumab, subcutaneous tocilizumab, and intravenous tocilizumab in patients with rheumatoid arthritis: the ANSWER cohort study Akira Onishi (Kyoto Univ. Graduate School of Medicine, Japan)

±³À°½Ã°£ 05¿ù 18ÀÏ Room 2 10:40~10:50 (±¸¿¬ ¹ßÇ¥) Real-world comparative effectiveness study of Janus Kinase inhibitors compared to biologic disease modifying antirheumatic drugs in Korean patients with rheumatoid arthritis Á¶¼ö°æ(ÇѾç´ëÇб³)

±³À°½Ã°£ 05¿ù 18ÀÏ Room 2 10:50~11:00 (±¸¿¬ ¹ßÇ¥) Effectiveness of tumor necrosis factor inhibitors in combination with MTX or non-MTX csDMARDs in patients with rheumatoid arthritis: Data from the KOBIO registry ±è¹ÎÁ¤(¼­¿ï´ëÇб³)

±³À°½Ã°£ 05¿ù 18ÀÏ Room 2 11:00~11:10 (±¸¿¬ ¹ßÇ¥) Influence of fat mass and sarcopenia on treatment response of targeted therapy in rheumatoid arthritis: A single-center prospective study ±èÁö¿ø(°¡Å縯´ëÇб³)

±³À°½Ã°£ 05¿ù 18ÀÏ Room 2 11:10~11:20 (±¸¿¬ ¹ßÇ¥) Predicting methotrexate response in early rheumatoid arthritis using machine learning analysis of joint ultrasound imaging Rifaldy Fajar(Karlstad Univ., Sweden)

±³À°½Ã°£ 05¿ù 18ÀÏ Room 2 11:20~11:30 (±¸¿¬ ¹ßÇ¥) Increased risk of cancer in patients with systemic sclerosis: A population-based study Àº¿µÈñ (¼º±Õ°ü´ëÇб³)

±³À°½Ã°£ 05¿ù 18ÀÏ Room 2 11:30~11:40 (±¸¿¬ ¹ßÇ¥) Cancer incidence and impact of immunosuppressive agents in Korean systemic lupus erythematosus patients ÇÑÁ¤¿ë (ÇѾç´ëÇб³)

±³À°½Ã°£ 05¿ù 18ÀÏ Room 2 11:40~11:50 (±¸¿¬ ¹ßÇ¥) Risk of gynecologic cancer among Korean women of childbearing age with rheumatic diseases ÀÌÁö¼ö(ÀÌÈ­¿©´ë)

±³À°½Ã°£ 05¿ù 18ÀÏ Room 2 11:50~12:00 (±¸¿¬ ¹ßÇ¥) Long-term cancer risk of tumor necrosis factor inhibitors in ankylosing spondylitis: A single-center cohort study ÀÌ¿©Áø (¿ï»ê´ëÇб³)

±³À°½Ã°£ 05¿ù 18ÀÏ Room 2 12:00~12:40 Putting the Patient First : The Value of SHINGRIX for Rheumatologic Patient ¹Ú¿µÀç(°¡Å縯´ëÇб³)

±³À°½Ã°£ 05¿ù 18ÀÏ Room 2 13:00~13:30 Clinical and Laboratory Approach to Juvenile Idiopathic Arthritis ±è¿µ´ë(Inje Univ., Korea)

±³À°½Ã°£ 05¿ù 18ÀÏ Room 2 13:30~14:00 Juvenile Dermatomyositis; Updates ÀÓÁ¤¿ì(°¡Å縯´ëÇб³)

±³À°½Ã°£ 05¿ù 18ÀÏ Room 2 14:00~14:30 Advances in Still's Disease (systemic JIA, AOSD) ±èÇö¾Æ(¾ÆÁÖ´ëÇб³)

±³À°½Ã°£ 05¿ù 18ÀÏ Room 3 08:00~08:40 Treatment Option (Adalimumab) for RA patients ±èÇö¾Æ(¾ÆÁÖ´ëÇб³)

±³À°½Ã°£ 05¿ù 18ÀÏ Room 3 10:30~10:40 (±¸¿¬ ¹ßÇ¥) Association of rheumatoid arthritis with age-related macular degeneration: A nationwide cohort study Àº¿µÈñ(¼º±Õ°ü´ëÇб³)

±³À°½Ã°£ 05¿ù 18ÀÏ Room 3 10:40~10:50 (±¸¿¬ ¹ßÇ¥) The status of baseline screening ophthalmologic examinations in patients with rheumatic diseases starting hydroxychloroquine using Health Insurance Review and Assessment Service database ±è¾Æ¶õ(ºÎ»ê´ëÇб³)

±³À°½Ã°£ 05¿ù 18ÀÏ Room 3 10:50~11:00 (±¸¿¬ ¹ßÇ¥) Prevalence and risk factors of non-alcoholic fatty liver disease in patients with rheumatoid arthritis: a nationwide population-based study Shiyu Xiao(Sichuan Academy of Medical Science and Sichuan Provincial People)

±³À°½Ã°£ 05¿ù 18ÀÏ Room 3 11:00~11:10 (±¸¿¬ ¹ßÇ¥) Infertility and the chance of successful assisted assisted reproductive therapy in childbearing women with rheumatic diseases Á¤¹Î°æ(ÀÌÈ­¿©´ë)

±³À°½Ã°£ 05¿ù 18ÀÏ Room 3 11:20~11:30 (±¸¿¬ ¹ßÇ¥) Pregnancy risk and undifferentiated connective tissue disease Fangning You(Chongqing Hosp. of Traditional Chinese Medicine, China)

±³À°½Ã°£ 05¿ù 18ÀÏ Room 3 11:30~11:40 (±¸¿¬ ¹ßÇ¥) A novel scoring system to predict serious infections in patients with rheumatic diseases receiving prolonged, high-dose glucocorticoid treatment ÃÖ¼¼¸²(¼­¿ï´ëÇб³)

±³À°½Ã°£ 05¿ù 18ÀÏ Room 3 11:40~11:50 (±¸¿¬ ¹ßÇ¥) Incidence of systemic vasculitides after Mycobacterium tuberculosis infection: A population-based cohort study in Korea ¾È¼º¼ö(¿¬¼¼´ëÇб³)

±³À°½Ã°£ 05¿ù 18ÀÏ Room 3 11:50~12:00 (±¸¿¬ ¹ßÇ¥) Human papillomavirus vaccination awareness in Chinese autoimmune inflammatory rheumatic diseases: a large real-world survey Juan Zhao(Peking Univ. First Hosp., China)

±³À°½Ã°£ 05¿ù 18ÀÏ Room 3 12:00~12:40 What Remission Means to Patients Versus to HCPs: Closing the Gap with Rinvoq õÀ±È« (°æ»ó´ëÇб³)

±³À°½Ã°£ 05¿ù 18ÀÏ Room 3 13:00~13:10 (±¸¿¬ ¹ßÇ¥) Utility of a multi-biomarkers panel on predicting disease activity in patients with psoriatic arthritis – a derivation and validation study Yingzhao Jin(Hong Kong, The Chinese Univ. of Hong Kong, Hong Kong)

±³À°½Ã°£ 05¿ù 18ÀÏ Room 3 13:10~13:20 (±¸¿¬ ¹ßÇ¥) Using RNA-Seq data of TgA86 mouse model of spondyloarthritis ±è¼¼Èñ(°æÈñ´ëÇб³)

±³À°½Ã°£ 05¿ù 18ÀÏ Room 3 13:20~13:30 (±¸¿¬ ¹ßÇ¥) Aortic inflammation and Wnt signaling undergo activation in the context of spondyloarthritis in the HLA-B27 transgenic rat model ±Ç¼º·Ä(ÀÎÇÏ´ëÇб³ )

±³À°½Ã°£ 05¿ù 18ÀÏ Room 3 13:30~13:50 ·ù¸¶Æ¼½º³»°ú Àǻ簡 »ý°¢ÇÏ´Â ÇʼöÀÇ·áÀÇ Á¤ÀÇ À±º¸¿µ(ÀÎÁ¦´ëÇб³)

±³À°½Ã°£ 05¿ù 18ÀÏ Room 3 13:50~14:10 ·ù¸¶Æ¼½ºÁúȯÀÇ Áø·á ¼ö¿ä¿Í º´¿øº° ¿ªÇÒ, ±×¸®°í±³À°ÇÁ·Î±×·¥ °³ÆíÀÇ Çʿ伺 ±è±ÙÅÂ(°í½Å´ëÇб³)

Åä·Ð 05¿ù 18ÀÏ Room 3 14:10~14:30 Panel Discussion ()

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ 44th Korean College of Rheumatolgy Annual Scientific Meeting and the 18th International Symposium (KCR2024)-¼Â°³¯ : 2024-05-18""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Áß¾Ó´ëÇб³º´¿ø ¾È°ú ½ÉÆ÷Áö¾ö : 2024-05-18
´ÙÀ½±Û Á¦7ȸ °­ºÏ±¸ÀÇ»çȸ Çмú´ëȸ : 2024-05-18
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 29 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 28 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 33 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 40 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 30 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 23 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 8 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 9 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 18 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 12 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 9 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 25 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 13 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 21 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 17 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷